Home

Tang Capital Management reported a 5.3% stake in Spyre Therapeutics SYRE · 3,200,000 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
5.3%
Last report
First report
Shares held
3,200,000 sh
Class
Common Stock, par value $0.0001 per share
Event date
25/04/24
Filed
25/05/01

First 5%+ report · 5.3% stake

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/25~25/05/24

Tang Capital Management's other 5% stake reports

Tang Capital Management reported a 5.3% stake in Spyre Therapeutics SYRE · 3,200,000 sh · passive holder | Whalegun